M. Altinoz Et Al. , "Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity," CANCER MEDICINE , vol.9, no.16, pp.5767-5780, 2020
Altinoz, M. Et Al. 2020. Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity. CANCER MEDICINE , vol.9, no.16 , 5767-5780.
Altinoz, M., Ucal, Y., Yilmaz, M., Kiris, İ., Ozisik, O., Sezerman, U., ... Ozpinar, A.(2020). Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity. CANCER MEDICINE , vol.9, no.16, 5767-5780.
Altinoz, MA Et Al. "Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity," CANCER MEDICINE , vol.9, no.16, 5767-5780, 2020
Altinoz, MA Et Al. "Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity." CANCER MEDICINE , vol.9, no.16, pp.5767-5780, 2020
Altinoz, M. Et Al. (2020) . "Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity." CANCER MEDICINE , vol.9, no.16, pp.5767-5780.
@article{article, author={MA Altinoz Et Al. }, title={Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity}, journal={CANCER MEDICINE}, year=2020, pages={5767-5780} }